Antibody Response to Sars-Cov-2 Vaccination in Patients Following Allogeneic Hematopoietic Cell Transplantation

Mostrar otras versiones (1)

Background: Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been approved rapidly. However, pivotal studies have been conducted in healthy volunteers, while recipients of allogeneic hematopoietic cell transplantations (allo-HCT) may have different dynamics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicin-Sain, Caroline, Huang, Alice, Pasin, Chloe, Epp, Selina, Mueller, Nicolas J, Nilsson, Jakob, Vilinovszki, Oliver, Nair, Gayathri, Wolfensberger, Nathan, Hockl, Philipp, Schanz, Urs, Trkola, Alexandra, Kouyos, Roger, Hasse, Barbara, Zinkernagel, Annelies, Manz, Markus G, Abela, Irene A, Mueller, Antonia MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
722.Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701555/
http://dx.doi.org/10.1182/blood-2021-152100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701555/
http://dx.doi.org/10.1182/blood-2021-152100

Ejemplares similares